使用不同阿片类药物的OPRM1 A118G多态的效果比较:一项前性研究
Miho Takemura1, Kazuyuki Niki1, Yoshiaki Okamoto2
1Department of Clinical Pharmacy Research and Education (M.T., K.N., K.I.), Osaka University Graduate School of Pharmaceutical Sciences, Suita, Osaka, Japan; Department of Pharmacy (M.T., K.N., Y.O.), Ashiya Municipal Hospital, Ashiya, Hyogo, Japan.
Journal of pain and symptom management
|September 27, 2023
概括
OPRM1 A118G的多态性影响了阿片类药物的疗效. 塔潘达多尔和甲对于G基基基基因携带者来说比摩,氧和芬太尼更有效.
科学领域:
- 药物基因组学 药物基因组学
- 疼痛管理 疼痛管理
- 遗传学 是一个遗传学.
背景情况:
- 的μ-阿片类受体基因 (OPRM1) A118G多态 (rs1799971) 影响μ-阿片类受体糖化.
- G-基因基因携带者对吗啡的反应减弱,但对其他阿片类药物的数据有限.
研究的目的:
- 调查OPRM1 A118G多态对各种阿片类止痛药在癌症疼痛管理中的疗效的影响.
主要方法:
- 一项前性队列研究包括222名癌症患者,这些癌症患者接受了塔潘达多尔,甲,水墨,氧化或透皮芬太尼.
- 与基线相比,在第3,7和14天的简短疼痛清单-简短形式得分的变化与基因型和阿片类药物治疗进行了比较.
主要成果:
- 在OPRM1 A118G基因型之间,没有观察到塔潘塔多尔或美沙对疼痛评分减少的显著差异.
- 与AA同卵性患者相比,G-基因基因携带者在用摩,氧化和芬太尼时显示出明显较小的疼痛缓解.
结论:
- 塔潘塔多尔和甲似乎更适合于G基因基因携带者,因为它们的双重机制和对OPRM1 A118G多态效应的敏感性较低.
- 在G-基因基因携带者中,色胺,氧化和芬太尼的疗效可能会受到损害.
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
326
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
326
Opioid Receptors: Overview
984
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
984
Opioid Analgesics: Morphine and Other Natural Cogeners
283
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
283
Analgesia and Pain Management
649
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
649
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
230
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
230
Analysis of Population Pharmacokinetic Data
282
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
282


